{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:11:56Z","timestamp":1788487916167,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024838","name":"Samsung Medical Center, Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-KH135936"],"award-info":[{"award-number":["RS-2023-KH135936"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["SMO1250321"],"award-info":[{"award-number":["SMO1250321"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tiv.2026.106266","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:59:34Z","timestamp":1780531174000},"page":"106266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro assessment of cetalkonium chloride induced damage in human corneal keratocytes"],"prefix":"10.1016","volume":"116","author":[{"given":"Yengwoo","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choul Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2026.106266_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jfo.2014.05.001","article-title":"Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomized comparative study","volume":"37","author":"Amrane","year":"2014","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.tiv.2026.106266_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jphp.12075","article-title":"Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery","volume":"66","author":"Daull","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106266_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/jop.2020.0043","article-title":"High-frequency application of cationic agents containing lubricant eye drops causes cumulative corneal toxicity in an ex vivo eye irritation test model","volume":"36","author":"Dutescu","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2026.106266_bb0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2147\/OPTH.S258081","article-title":"Efficacy and safety of VisuEvo\u00ae and Cationorm\u00ae for the treatment of evaporative and non-evaporative dry eye disease: a Multicenter, double-blind, cross-over, randomized clinical trial","volume":"14","author":"Fogagnolo","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.tiv.2026.106266_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","article-title":"Ocular benzalkonium chloride exposure: problems and solutions","volume":"36","author":"Goldstein","year":"2022","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.tiv.2026.106266_bb0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tiv.2019.04.027","article-title":"Effects of benzalkonium chloride on cell viability, inflammatory response, and oxidative stress of human alveolar epithelial cells cultured in a dynamic culture condition","volume":"59","author":"Jeon","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2026.106266_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tiv.2026.106266_bb0040","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.3390\/ma14154290","article-title":"Recent advances in the excipients used for modified ocular drug delivery","volume":"14","author":"Koutsoviti","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.tiv.2026.106266_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine a delivery to the eye: a comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2026.106266_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120924","article-title":"Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2026.106266_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv. Ther."},{"key":"10.1016\/j.tiv.2026.106266_bb0060","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/IJG.0000000000001655","article-title":"Economic and environmental impact of single-use plastics at a large ophthalmology outpatient service","volume":"29","author":"Park","year":"2020","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.tiv.2026.106266_bb0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/pharmaceutics17040522","article-title":"In vitro toxicity of cetalkonium chloride on corneal epithelial cells","volume":"17","author":"Park","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tiv.2026.106266_bb0070","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1038\/s41598-021-87791-x","article-title":"Nitric oxide attenuated transforming growth factor-\u03b2 induced myofibroblast differentiation of human keratocytes","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106266_bb0075","article-title":"Cetalkonium chloride induced a dose-dependent toxicity on corneal endothelial cells","author":"Park","year":"2025","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2026.106266_bb0080","article-title":"Benzalkonium chlorides: uses, regulatory status, and microbial resistance","volume":"85","author":"Pereira","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tiv.2026.106266_bb0085","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1038\/s41598-025-96919-2","article-title":"Assessment of the toxic effect of benzalkonium chloride on human limbal stem cells","volume":"15","author":"Prusek","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106266_bb0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5301\/ejo.5000830","article-title":"Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study","volume":"26","author":"Robert","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.tiv.2026.106266_bb0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1167\/iovs.16-20603","article-title":"The effects of nonporous silica nanoparticles on cultured human keratocytes","volume":"58","author":"Yim","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:47Z","timestamp":1788484427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233326000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S0887233326000743"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106266","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assessment of cetalkonium chloride induced damage in human corneal keratocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106266"}}